Eris Pharma to launch Rs 1,800 crore IPO in June

http://ift.tt/2mP7edw
Chrys Capital backed Eris Lifesciences is set to raise Rs 1800 crore through an IPO shortly. The IPO will give an exit to Chrys Capital, which holds around 16.25 percent in the company. Eris Lifesciences Managing Director Amit Bakshi spoke to CNBC TV18#39;s Vikas Dandekar and said that the company is looking at growing in the range of 18 percent to 20 percent, ahead of the industry rate of 10 percent to 12 percent.

June 08, 2017 at 08:35AM

http://ift.tt/2rXQL92

from

http://ift.tt/2rXQL92